Table 4.
Glucose Quintiles | 30-day MACEs | ||
OR (95% CI), p-value | |||
Model 1 | Model 2 | Model 3 | |
Patients with NSTEMI | |||
Q1 | 1.31 (0.83, 2.09) p = 0.251 | 1.31 (0.82, 2.09) p = 0.258 | 1.21 (0.73, 2.02) p = 0.452 |
Q2 | reference | reference | reference |
Q3 | 1.44 (0.91, 2.28) p = 0.121 | 1.34 (0.84, 2.14) p = 0.212 | 1.22 (0.73, 2.03) p = 0.442 |
Q4 | 1.04 (0.63, 1.70) p = 0.886 | 1.01 (0.62, 1.67) p = 0.955 | 0.85 (0.50, 1.47) p = 0.573 |
Q5 | 1.92 (1.24, 2.98) p = 0.004 | 1.83 (1.17, 2.85) p = 0.008 | 1.40 (0.84, 2.34) p = 0.191 |
Patients with STEMI | |||
Q1 | 0.93 (0.63, 1.37) p = 0.703 | 0.91 (0.61, 1.35) p = 0.634 | 0.89 (0.58, 1.36) p = 0.584 |
Q2 | reference | reference | reference |
Q3 | 1.07 (0.75, 1.54) p = 0.712 | 1.06 (0.74, 1.54) p = 0.746 | 1.04 (0.69, 1.56) p = 0.848 |
Q4 | 1.55 (1.10, 2.19) p = 0.013 | 1.56 (1.09, 2.21) p = 0.014 | 1.47 (0.98, 2.20) p = 0.061 |
Q5 | 1.91 (1.37, 2.66) p 0.001 | 2.02 (1.44, 2.84) p 0.001 | 2.23 (1.48, 3.35) p 0.001 |
p for interaction | 0.064 | 0.054 | 0.036 |
Model 1: adjusted for none. Model 2: adjusted for intervention, age, sex and SBP. Model 3: adjusted for intervention, age, sex, SBP, weight, heart rate, HDL-C, LDL-C, TG, smoking or tobacco, diabetes, hypertension, PAD, Symptom onset to arrival, Prior TIA or stroke, cardiac arrest at admission, LVEF category, PCI, antiplatelet, beta blocker. MACEs, major adverse cardiovascular events; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; SBP, systolic blood pressure; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; PAD, peripheral artery disease; TIA, transient ischemic attack; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; OR, odds ratio; CI, confidence interval.